Abacavir does not influence the rate of sustained virological response in HIV-HCV co-infected patients treated with pegylated interferon and weight adjusted ribavirin

INTRODUCTION: Combination of pegylated-interferon (PEG-IFN) plus ribavirin (RBV) is the standard-of-care for hepatitis C virus (HCV) treatment in HIV coinfected individuals. In 2007, abacavir (ABC)-based antiretroviral therapy was for the first time reported to be associated with early virological f...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: N, Laufer, M, Laguno, I, Perez, C, Cifuentes, J, Murillas, F, Vidal, L, Bonet, S, Veloso, JM, Gatell, J, Mallolas
Формат: Artigo
Язык:Inglês
Опубликовано: 2008
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2883773/
https://ncbi.nlm.nih.gov/pubmed/19043930
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы